to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Dr. Todd O’Brien has additional challenges beyond those encountered by most startup life science CEOs. The 48-year-old podiatrist still sees patients even while developing his latest innovation: an electronic tuning fork for measuring diabetes-related nerve damage in people’s feet. He's also building his company in Orono, Maine - far from any major healthcare hub.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
One way for life science and digital health entrepreneurs to innovate: turn landmark literature into accessible, web-based programs.
That’s what Omada Health, a San Francisco startup, has done for diabetes prevention. In a session on the future of intervention at the FutureMed conference at Singularity University in the Silicon Valley last week, the company’s co-founder and CEO Sean Duffy explained the effort.
Are bioresorbable stents from one company better than another? Arterial Remodeling Technologies thinks so. The company boasts that its stents offer faster and smoother bioresorption and crack-free expansion.
A treatment for tinnitus is the goal of two Ohio University colleagues who were frustrated by the lack of options for those suffering from this hearing disorder. Read more to find out how this medical device differs from its competitors.
In medical business news, imaging software firm Riverain Medical hopes to boost sales of a product that helps detect lung cancer. The company’s technology allows radiologists to see behind ribs and clavicles to get a better view of pulmonary nodules. Read more about this company’s promising future.
Choosing the right clinical research organization plays a key role in a successful clinical trial. Read about how to tell whether a CRO is a good fit for your company.
Biotech companies will have a new resource in the Ohio University Innovation Center’s new biotech research and development facility. Read more to learn about what it will offer.
Biotech companies will no longer be able to use wet laboratory space at Cincinnati incubator BioStart in September. However, the organization will continue to offer other services, such as market research, business model assistance and team-building support.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
© 2013 Ewing Marion Kauffman Foundation. All Rights Reserved.